Furthermore, even NK cells from mice lacking β2-microglobulin, which were known to be functionally dampened, inhibited pre-B cell proliferation as well. Thus, activated NK cells, which were expanded selectively by IL-15, could potentially regulate B lymphopoiesis through IFN-γ beyond the selection imposed upon self-recognition.
Introduction
It has been well documented that natural killer (NK) cells are a critical parameter for successful bone marrow (BM) transplantation [1] . Natural cytotoxicity of NK cells played an essential role in the inhibition of reconstitution of host hematopietic system by allogenic BM transplants. In contrast, NK cells are unable to kill autologous cells.
This "self tolerance" was considered to be mediated through inhibitory signals delivered by multiple killer inhibitory receptors (KIRs) that recognize self major histocompatibility complex -encoded class I (MHC-I) molecules [2] . On the other hand, self MHC-I molecules were proposed to play critical roles in the acquisition of functional competence by developing NK cells ("licencing") [3] . Similarly as natural cytotoxicity, production of the potent immunoregulatory cytokine interferon (IFN)-γ also seemed to require "licencing" [3] . In accordance with the hypothesis, NK cells in β2-microglobulin-deficient (β2m -/-) mice fail to produce IFN-γ efficiently in response to the stimuli through activating NK receptors as well as to exhibit natural cytotoxicity [3] [4] [5] .
In addition to the effects on allogenic cells, NK cells were reported to have potential to functionally inhibit autologous dendritic cells under certain circumstances [6, 7] , suggesting that NK cells could act beyond "self tolerance" to exert their immunoregulatory functions. However, questions are to be addressed as to under what conditions and how NK cells escape "self tolerance". Cytokines such as interleukin (IL)-2 might enable NK cell to overcome "self tolerance" [3, 8] . Unlike IL-2, IL-15 is well known not only to be essential for NK cell development and proliferation, but also to play important roles in inflammation, acting in conjunction with other proinflammatory cytokines such as IL-12 and IL-18 [9] [10] [11] . Its potential to enable NK Nakajima et al.
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cells to overcome "self tolerance" is to be examined.
NK cells were heterogeneous both in mice and humans, comprising of mature NK cell subsets as well as cells of various maturation stages [12] . In contrast to the well-known mature NK cell subsets in humans distinguished by CD56 expression, murine NK cell subsets have just recently been identified using various cell surface were purchased from B&K Universal. IL-15 -/-mice [9] were from Taconic Farm.
β2m
-/-mice and RAG-1 -/-mice were described previously [21] . All these mice were backcrossed at least 10 times to C57BL/6 mice and kept under specific pathogen-free conditions in the animal facility of Shinshu University. All animal experiments were approved by the Committee for Animal Experimentation of Shinshu University and conducted according to the guideline.
Reagents
FITC-, PE-or biotin-conjugated monoclonal antibodies (mAb) for CD19, B220/CD45R
and CD49b/DX5 were purchased from BD Pharmingen. PE-anti-T cell receptor β-chain (TCRβ), APC-anti-CD93, APC-anti-NK1.1, biotin-anti-TER-119 and PE-Cy7-anti-Mac-1/CD11b mAbs were from eBioscience. FITC-anti-δ mAb and PE-goat anti-μ antibody were from Southern Biotech and Biomeda, respectively.
Biotin-labeled mAbs was developed with PE-Cy7-streptavidin (BD Pharmingen).
Anti-CD16/32 mAb was used to block Fc-mediated binding of antibodies during staining and cell sorting. Recombinant mouse IL-7 and IL-15 were purchased from PeproTech. Recombinant human IL-2 was provided by Ajinomoto Co., Inc (Kawasaki, Japan). Anti-IFN-γ (XMG1.2) mAb was from BD Pharmingen.
Cell culture, flowcytometry and ELISA Nakajima et al. 
Cell proliferation assays
BM cells were cultured for 3 days as described above. On day 3, bromodeoxyuridine (BrdU, 10 μM, BD Pharmingen) was added for further 6 hours. BrdU-labelled cells (Fig.1B, C) .
Importantly, IL-15-expanded NK cells were uniformly B220 + and expressing Mac-1, albeit at slightly lower levels than those on fresh NK cells (Fig.1D) , closely resembling recently identified NK cells presumably equivalent to human CD56 + NK cells [14, 15] .
They were also positive for c-kit, CD51 and CD69 (Nakajima, unpublished observations), suggesting that IL-15 expands not all but a subset of NK cells.
Pivotal role for IFN-γ produced by NK cells in the inhibition of pre-B cell
proliferation.
BM cells depleted of NK cells by means of anti-NK1.1 ( Fig.2A) (Fig.2B ). In addition, exogenous NK cells added to the IL-15 -/-BM cultures inhibited pre-B cell proliferation in a cell number dependent manner (Fig.2B) . Thus, NK cells were not only required but also sufficient to mediate the inhibition by IL-15.
BM cells from mice lacking IFN-α/β receptors (IFNAR1 -/-mice) were as sensitive to the inhibition by IL-15 as wild-type BM cells (Fig.2C) . Notably, also in the absence of IL-15, wild-type and IFNAR1 -/-pre-B cells proliferated at equal efficiencies (Fig.2C , open columns), indicating that IFN-α/β were dispensable to inhibit pre-B cell proliferation under the culture conditions. We observed that IFN-γ was indeed produced within the BM cultures in a manner dependent on both IL-15 and mature NK cells (Fig.2D) . IFN-γ thus produced appeared to almost exclusively mediate the NK cell function to inhibit pre-B cell proliferation, as BM cells isolated from mice lacking IFN-γ receptors (IFNGR1 -/-) restored dramatically the recovery of CD19 + cells (Fig.2E ).
In agreement with this conclusion, neutralizing antibodies against IFN-γ also increased CD19 + cell recovery significantly (Fig.2F) . Taken 
IFN-γ inhibited pre-B cell cycles.
Compared with B-lineage cells recovered from BM cultures containing IL-7 alone, those recovered from cultures containing both IL-7 and IL-15 exhibited reduction in the incorporation of BrdU (Fig.3A) . In contrast, IFNGR1 -/-cells did not show such a Nakajima et al. (Fig.3A) . (Fig.4A) . Furthermore, the amounts of IFN-γ produced in β2m -/-BM cultures were comparable to those in wild-type BM cultures and IFN-γ appeared to be derived largely from NK cells (Fig. 4B ). These observations indicated that NK cells in β2m -/-mice acted as an inhibitor of pre-B cell proliferation through the mechanism identical to that of wild-type NK cells.
reduction in BrdU incorporation

Discussion
It has been shown that IL-15 acted directly on activated mature B cells to induce proliferation and plasma cell differentiation [23] . We showed here that IL-15 could also influence B cell expansion in vitro through inhibiting IL-7-driven pre-B cell proliferation. Such an inhibitory function was indirect and mediated by NK cell-derived IFN-γ. Exogenously supplemented IFN-γ was previously shown to inhibit pre-B cell proliferation, but it is not fully clear if the mechanism for such an IFN-γ function involve the induction of apoptosis by this cytokine [19, 20] . We observed that few pre-B cells were undergoing apoptosis (Nakajima, unpublished observation) and IFN-γ seemed rather to reduce cell cycling efficiencies of pre-B cells (Fig.3) .
Although the absence of apoptotic pre-B cells might possibly be due to the rapid disappearance of these cells, these observations were consistent with a previous report [20] . Notwithstanding the apparent potential of IFN-γ in pre-B cell inhibition, the cellular source(s) of IFN-γ has not been identified. Our current study demonstrated in this regard that Mac-1 + B220 + NK cells selectively expanded by IL-15 (Fig.1D) , likely representing the activated NK cell subset with potent IFN-γ producing activity [14, 15] , appeared to be one of the major sources of IFN-γ for pre-B cell inhibition.
B lymphopenia appears to be a complex process in which distinct mechanisms seemed to be operating individually or in concert according to the sorts of stimuli and timing.
Thus, in mice suffering from inflammations and infections, B cell generation was known to be inhibited by IFN-α/β [16] , although it was not fully clear if IFN-α/β acted directly on pre-B cells, as well as by mobilizing pre-B cells to the periphery from BM through reducing local concentrations of CXCL12 [24] . In our in vitro culture system, however, IFN-α/β did not affect pre-B cell proliferation supported by IL-7 (Fig.2C) , presumably because the amounts of IFN-α/β produced in situ under our cultures were too low, compared with those used in previous studies [17, 18] . Since IFN-α/β induced IL-15 during infections [25] and IFN-α/β were also a potent activator of NK cells [26] , IL-15 and NK cells could mediate the inhibitory activity of IFN-α/β on B lymphopoiesis in vivo [16, 18] . It was indeed known that virus infection induced IL-15 production rapidly and augments cytotoxic activity of NK cells [27] . Our in vitro culture system might mimic the in vivo process taking place after IL-15 was produced.
On the contrary, however, a previous report claimed that B cell engraftment upon autologous BM transplantation was accelerated by co-transplantation of IL-2-activated NK cells [28] . Although IFN-γ production was not examined in that report, IFN-γ 
